EKSO vs BLFS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BLFS Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioLife Solutions Inc. (BLFS) driven by superior Valuation, Growth & Margin, Options & Structure while EKSO counters with relative strength in Momentum & Technical. Fundamentally, EKSO trades at N/M Forward P/E with -119.7% operating margin (-38.3% YoY revenue) versus BLFS at 117.0x Forward P/E and 6.0% operating margin (+21.5% YoY). In options structure, EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BLFS sits in BREAKOUT (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EKSO | BLFS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $42.0M | $1.8B | Larger Scale | BLFS |
| Trailing P/E Ratio Valuation | N/M | 37.3x | Lower Multiple | BLFS |
| Forward P/E Ratio Valuation | N/M | 117.0x | Lower Multiple | BLFS |
| Revenue Growth (YoY) Growth | -38.3% | +21.5% | Higher Growth | BLFS |
| Operating Margin (TTM) Profitability | -119.7% | 6.0% | Higher Margin | BLFS |
| Net Profit Margin Profitability | -91.4% | 54.4% | Higher Margin | BLFS |
| Return on Equity (ROE) Capital Efficiency | -107.6% | 12.8% | Higher ROE | BLFS |
| 52-Week Range Position Momentum | 87% ($0โ$14) | 95% ($18โ$40) | Stronger Trend | BLFS |
| Beta / 30D Volatility Risk Regime | 2.16ฮฒ ยท 76% Vol | 1.05ฮฒ ยท 31% Vol | Lower Realized Risk | BLFS |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 46.0 / 100 (HOLD) | Higher Composite | EKSO |